[
  {
    "ts": "2026-01-02T13:34:38+00:00",
    "headline": "Equities to Get Boost From Robust Earnings in 2026 But Near-Term Fed Path Uncertain, Analysts Say",
    "summary": "US equity markets are poised to get a boost from strong corporate earnings this year as spending con",
    "url": "https://finance.yahoo.com/news/equities-boost-robust-earnings-2026-133438956.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "11fc1eab-d54d-3a9d-a538-886fa12cf048",
      "content": {
        "id": "11fc1eab-d54d-3a9d-a538-886fa12cf048",
        "contentType": "STORY",
        "title": "Equities to Get Boost From Robust Earnings in 2026 But Near-Term Fed Path Uncertain, Analysts Say",
        "description": "",
        "summary": "US equity markets are poised to get a boost from strong corporate earnings this year as spending con",
        "pubDate": "2026-01-02T13:34:38Z",
        "displayTime": "2026-01-02T13:34:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/mt_newswires_premium_news_706/6bb7c2fb42cf32701d68de803e00b0ef",
          "originalWidth": 1024,
          "originalHeight": 683,
          "caption": "wallstreetsign.jpg - Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lI5cIjBjU5eubUz1M.E4aA--~B/aD02ODM7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/mt_newswires_premium_news_706/6bb7c2fb42cf32701d68de803e00b0ef.cf.webp",
              "width": 1024,
              "height": 683,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pEfwAFBugUgkoc.pTwU_Jw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/mt_newswires_premium_news_706/6bb7c2fb42cf32701d68de803e00b0ef.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/equities-boost-robust-earnings-2026-133438956.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/equities-boost-robust-earnings-2026-133438956.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T15:50:35+00:00",
    "headline": "Pfizer (PFE) Navigates Patent Losses With Strategic Cost Controls, BMO Capital Reaffirms Outperform Rating",
    "summary": "Pfizer Inc. (NYSE:PFE) ranks among the best stocks under $25 to buy now. Citing the company’s cautious 2026 outlook, BMO Capital reaffirmed its Outperform rating and $30 price target for Pfizer Inc. (NYSE:PFE) on December 17. The pharmaceutical company anticipates adjusted profit to be between $2.80 and $3 per share in the upcoming year. In […]",
    "url": "https://finance.yahoo.com/news/pfizer-pfe-navigates-patent-losses-155035704.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "aeba70a0-bdb2-35a9-b01c-f503b45b5cb0",
      "content": {
        "id": "aeba70a0-bdb2-35a9-b01c-f503b45b5cb0",
        "contentType": "STORY",
        "title": "Pfizer (PFE) Navigates Patent Losses With Strategic Cost Controls, BMO Capital Reaffirms Outperform Rating",
        "description": "",
        "summary": "Pfizer Inc. (NYSE:PFE) ranks among the best stocks under $25 to buy now. Citing the company’s cautious 2026 outlook, BMO Capital reaffirmed its Outperform rating and $30 price target for Pfizer Inc. (NYSE:PFE) on December 17. The pharmaceutical company anticipates adjusted profit to be between $2.80 and $3 per share in the upcoming year. In […]",
        "pubDate": "2026-01-02T15:50:35Z",
        "displayTime": "2026-01-02T15:50:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/53fde57e3df2e60396843254655c57ca",
          "originalWidth": 800,
          "originalHeight": 480,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6WTGkeph75pOVhavnybpiw--~B/aD00ODA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/53fde57e3df2e60396843254655c57ca.cf.webp",
              "width": 800,
              "height": 480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DK4Jv.eKjvFvm3Ar9OASuQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/53fde57e3df2e60396843254655c57ca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-navigates-patent-losses-155035704.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-pfe-navigates-patent-losses-155035704.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T14:51:00+00:00",
    "headline": "Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in China",
    "summary": "Novo Nordisk cuts Wegovy prices in China, which may shift investor focus toward diversified healthcare ETFs.",
    "url": "https://finance.yahoo.com/news/spotlight-health-etfs-nvo-lly-145100642.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "bb9f3282-49ac-31b5-a467-31f9dc7f4c90",
      "content": {
        "id": "bb9f3282-49ac-31b5-a467-31f9dc7f4c90",
        "contentType": "STORY",
        "title": "Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in China",
        "description": "",
        "summary": "Novo Nordisk cuts Wegovy prices in China, which may shift investor focus toward diversified healthcare ETFs.",
        "pubDate": "2026-01-02T14:51:00Z",
        "displayTime": "2026-01-02T14:51:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/e66aa7ee2b50b297307d131c5d457a73",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3GkkLZFYbl52wnpptRqd1w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e66aa7ee2b50b297307d131c5d457a73.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a7SzRmhAvDPGiiSvT8MWFg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e66aa7ee2b50b297307d131c5d457a73.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/spotlight-health-etfs-nvo-lly-145100642.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/spotlight-health-etfs-nvo-lly-145100642.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "VHCIX"
            },
            {
              "symbol": "VHT"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PPH"
            },
            {
              "symbol": "IYH"
            },
            {
              "symbol": "IXJ"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "NVSEF"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-02T21:50:00+00:00",
    "headline": "2 Predictions for Pfizer in 2026",
    "summary": "The company's prospects are stronger than its stock-market performance in 2025 suggests.",
    "url": "https://www.fool.com/investing/2026/01/02/2-predictions-for-pfizer-in-2026/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "e7e10ec9-767c-3533-aa5e-a8bc6392f40c",
      "content": {
        "id": "e7e10ec9-767c-3533-aa5e-a8bc6392f40c",
        "contentType": "STORY",
        "title": "2 Predictions for Pfizer in 2026",
        "description": "",
        "summary": "The company's prospects are stronger than its stock-market performance in 2025 suggests.",
        "pubDate": "2026-01-02T21:50:00Z",
        "displayTime": "2026-01-02T21:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/6c367f5ba56966211a8edd6155d413ca",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Doctor and patient in a hospital room.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vY5Oldb8NwLa56SibLNqkw--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/6c367f5ba56966211a8edd6155d413ca.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V5qR.urkBPfXaBb13.I.1Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/6c367f5ba56966211a8edd6155d413ca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/02/2-predictions-for-pfizer-in-2026/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-predictions-pfizer-2026-215000366.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]